参考文献
1: Rogalska A, Bukowska B, Marczak A. Caspases and ROS - dependent mechanism of action mediated by combination of WP 631 and epothilone B. Anticancer Agents Med Chem. 2014;14(9):1261-70. PubMed PMID: 24913659.
2: Rogalska A, Gajek A, Marczak A. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells. Toxicol In Vitro. 2014 Jun;28(4):675-83. doi: 10.1016/j.tiv.2014.02.007. Epub 2014 Feb 26. PubMed PMID: 24583341.
3: Ceresa C, Avan A, Giovannetti E, Geldof AA, Avan A, Cavaletti G, Peters GJ. Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B. Anticancer Res. 2014 Jan;34(1):517-23. PubMed PMID: 24403510.
4: von Roemeling CA, Marlow LA, Kennedy WP, Kennedy GT, Copland JA, Menefee ME. Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma. Am J Cancer Res. 2013 Aug 14;3(4):390-401. eCollection 2013. PubMed PMID: 23977448; PubMed Central PMCID: PMC3744018.
5: Rogalska A, Gajek A, Marczak A. Analysis of epothilone B-induced cell death in normal ovarian cells. Cell Biol Int. 2013 Dec;37(12):1330-9. doi: 10.1002/cbin.10165. Epub 2013 Sep 12. PubMed PMID: 23955989.
6: Rogalska A, Szula E, Gajek A, Marczak A, Jóźwiak Z. Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B. Environ Toxicol Pharmacol. 2013 Sep;36(2):600-10. doi: 10.1016/j.etap.2013.06.003. Epub 2013 Jun 19. PubMed PMID: 23838010.
7: Churpek JE, Pro B, van Besien K, Kline J, Conner K, Wade JL 3rd, Hagemeister F, Karrison T, Smith SM. A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas. Cancer. 2013 May 1;119(9):1683-9. doi: 10.1002/cncr.27917. Epub 2013 Jan 10. PubMed PMID: 23310949.
8: Wang J, Sun BF, Cui K, Lin GQ. An efficient total synthesis of (-)-epothilone B. Org Lett. 2012 Dec 21;14(24):6354-7. doi: 10.1021/ol303148g. Epub 2012 Dec 7. PubMed PMID: 23214997.
9: Meier V, Geigy C, Grosse N, McSheehy P, Rohrer Bley C. Use of epothilone B (patupilone) in refractory lymphoma and advanced solid tumors in dogs. J Vet Intern Med. 2013 Jan-Feb;27(1):120-5. doi: 10.1111/jvim.12019. Epub 2012 Dec 3. PubMed PMID: 23205945.
10: Lu HM, Ye M. LC-MS/MS method for determination of epothilone B in rat plasma and its application in pharmacokinetic study. Arzneimittelforschung. 2012 Dec;62(12):609-13. doi: 10.1055/s-0032-1327695. Epub 2012 Oct 23. PubMed PMID: 23093482.
11: Baumgart T, Kriesen S, Hildebrandt G, Manda K. Effect of epothilone B on cell cycle, metabolic activity, and apoptosis induction on human epithelial cancer cells-under special attention of combined treatment with ionizing radiation. Cancer Invest. 2012 Oct;30(8):593-603. Epub 2012 Aug 21. PubMed PMID: 22909073.
12: Oehler C, Frei K, Rushing EJ, McSheehy PM, Weber D, Allegrini PR, Weniger D, Lütolf UM, Knuth A, Yonekawa Y, Barath K, Broggini-Tenzer A, Pruschy M, Hofer S. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology. 2012;83(1):1-9. doi: 10.1159/000339152. Epub 2012 Jun 8. PubMed PMID: 22688083.
13: Pagano A, Honoré S, Mohan R, Berges R, Akhmanova A, Braguer D. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends. Biochem Pharmacol. 2012 Aug 15;84(4):432-43. doi: 10.1016/j.bcp.2012.05.010. Epub 2012 May 23. PubMed PMID: 22634050.
14: Baumgart T, Klautke G, Kriesen S, Kuznetsov SA, Weiss DG, Fietkau R, Hildebrandt G, Manda K. Radiosensitizing effect of epothilone B on human epithelial cancer cells. Strahlenther Onkol. 2012 Feb;188(2):177-84. doi: 10.1007/s00066-011-0029-4. Epub 2012 Jan 12. PubMed PMID: 22234539.
15: Oehler C, von Bueren AO, Furmanova P, Broggini-Tenzer A, Orlowski K, Rutkowski S, Frei K, Grotzer MA, Pruschy M. The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells. Neuro Oncol. 2011 Sep;13(9):1000-10. doi: 10.1093/neuonc/nor069. Epub 2011 Jul 9. PubMed PMID: 21743064; PubMed Central PMCID: PMC3158010.
16: Gan PP, McCarroll JA, Byrne FL, Garner J, Kavallaris M. Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells. PLoS One. 2011;6(6):e21717. doi: 10.1371/journal.pone.0021717. Epub 2011 Jun 29. PubMed PMID: 21738778; PubMed Central PMCID: PMC3126859.
17: Pellicciotta I, Yang CP, Goldberg GL, Shahabi S. Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells. Gynecol Oncol. 2011 Sep;122(3):625-31. doi: 10.1016/j.ygyno.2011.05.007. Epub 2011 May 28. PubMed PMID: 21621254.
18: Vollmer LL, Jiménez M, Camarco DP, Zhu W, Daghestani HN, Balachandran R, Reese CE, Lazo JS, Hukriede NA, Curran DP, Day BW, Vogt A. A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos. Mol Cancer Ther. 2011 Jun;10(6):994-1006. doi: 10.1158/1535-7163.MCT-10-1048. Epub 2011 Apr 13. PubMed PMID: 21490306; PubMed Central PMCID: PMC3112307.
19: Schiess R, Gertsch J, Schweizer WB, Altmann KH. Stereoselective synthesis of 12,13-cyclopropyl-epothilone B and side-chain-modified variants. Org Lett. 2011 Mar 18;13(6):1436-9. doi: 10.1021/ol200114k. Epub 2011 Feb 21. PubMed PMID: 21338105.
20: Khrapunovich-Baine M, Menon V, Yang CP, Northcote PT, Miller JH, Angeletti RH, Fiser A, Horwitz SB, Xiao H. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation. J Biol Chem. 2011 Apr 1;286(13):11765-78. doi: 10.1074/jbc.M110.162214. Epub 2011 Jan 18. PubMed PMID: 21245138; PubMed Central PMCID: PMC3064228.
